Nicholas Hoffman & Company, Llc. Novartis Ag Transaction History

Nicholas Hoffman & Company, Llc.

$2.35 Billion
Q3 2024

A detailed history of Nicholas Hoffman & Company, Llc. transactions in Novartis Ag stock. As of the latest transaction made, Nicholas Hoffman & Company, Llc. holds 9,989 shares of NVS stock, worth $989,710. This represents 0.05% of its overall portfolio holdings.

Number of Shares

9,989

Previous 9,881 1.09%

Holding current value

$989,710

Previous $1.05 Million 9.23%

% of portfolio

0.05%

Previous 0.05%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$106.13 - $120.89 $11,462 - $13,056	108 Added 1.09%	9,989 $1.15 Million
Q2 2024 Aug 02, 2024	SELL	$92.57 - $107.37 $3,702 - $4,294	-40 Reduced 0.4%	9,881 $1.05 Million
Q1 2024 Apr 22, 2024	BUY	$95.27 - $108.47 $6,097 - $6,942	64 Added 0.65%	9,921 $959,000
Q3 2023 Nov 06, 2023	SELL	$94.73 - $105.13 $6,631 - $7,359	-70 Reduced 0.71%	9,857 $1 Million
Q2 2023 Aug 09, 2023	BUY	$92.52 - $104.91 $25,535 - $28,955	276 Added 2.86%	9,927 $1 Million
Q4 2022 Feb 13, 2023	BUY	$75.55 - $92.52 $755 - $925	10 Added 0.1%	9,651 $875,000
Q3 2022 Nov 04, 2022	BUY	$74.61 - $87.26 $19,398 - $22,687	260 Added 2.77%	9,641 $733,000
Q2 2022 Aug 09, 2022	SELL	$80.52 - $93.75 $16,989 - $19,781	-211 Reduced 2.2%	9,381 $793,000
Q1 2022 May 10, 2022	BUY	$80.11 - $90.62 $7,209 - $8,155	90 Added 0.95%	9,592 $842,000
Q4 2021 Feb 10, 2022	BUY	$79.7 - $88.13 $1,354 - $1,498	17 Added 0.18%	9,502 $831,000
Q3 2021 Nov 04, 2021	SELL	$81.78 - $95.14 $67,386 - $78,395	-824 Reduced 7.99%	9,485 $776,000
Q2 2021 Aug 10, 2021	BUY	$85.24 - $94.15 $4,517 - $4,989	53 Added 0.52%	10,309 $941,000
Q1 2021 May 11, 2021	BUY	$83.5 - $98.47 $119,154 - $140,516	1,427 Added 16.16%	10,256 $877,000
Q4 2020 Feb 11, 2021	BUY	$78.07 - $94.43 $2,107 - $2,549	27 Added 0.31%	8,829 $834,000
Q3 2020 Nov 12, 2020	BUY	$82.14 - $91.0 $60,701 - $67,249	739 Added 9.17%	8,802 $765,000
Q2 2020 Aug 12, 2020	BUY	$80.93 - $91.1 $37,227 - $41,906	460 Added 6.05%	8,063 $704,000
Q1 2020 May 11, 2020	BUY	$70.67 - $99.01 $27,137 - $38,019	384 Added 5.32%	7,603 $627,000
Q2 2019 Aug 12, 2019	SELL	$75.4 - $92.8 $35,136 - $43,244	-466 Reduced 6.06%	7,219 $659,000
Q1 2019 May 13, 2019	SELL	$75.32 - $86.15 $118,478 - $135,513	-1,573 Reduced 16.99%	7,685 $739,000
Q3 2018 Nov 09, 2018	SELL	$66.94 - $77.43 $20,416 - $23,616	-305 Reduced 3.19%	9,258 $798,000
Q2 2018 Aug 07, 2018	BUY	$64.91 - $73.36 $454 - $513	7 Added 0.07%	9,563 $722,000
Q1 2018 May 07, 2018	SELL	$70.39 - $84.15 $8,094 - $9,677	-115 Reduced 1.19%	9,556 $773,000
Q4 2017 Feb 09, 2018	SELL	$72.33 - $77.64 $45,423 - $48,757	-628 Reduced 6.1%	9,671 $812,000
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $43,668 - $45,512	589 Added 6.07%	10,299 $884,000
Q2 2017 Aug 14, 2017	BUY	N/A	9,710	9,710 $810,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $213B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Hoffman & Company, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Hoffman & Company, Llc. with notifications on news.

Account

Nicholas Hoffman & Company, Llc. Novartis Ag Transaction History